American Heart Association Urges Caution On New Diet Drug

December 10, 1997

DALLAS - The U.S. Food and Drug Administration recently approved Meridia (sibutramine), a new diet drug that has chemical properties similar, but not identical, to Redux and fen/phen (Pondimin).

Redux and fenfluramine, popular diet drugs, were voluntarily withdrawn from the market at the FDA's request after a report in the New England Journal of Medicine (vol. 337, #9, Aug. 28, 1997) linked valvular heart disease with the use of fen/phen, and prior reports linked pulmonary hypertension to the use of Redux (dexfenfluramine) alone.

Primary pulmonary hypertension is an often fatal disorder affecting the blood vessels in the lungs. Valvular heart disease occurs when the heart valve is damaged and either cannot open properly or doesn't close all the way and lets blood leak backward.

"The American Heart Association urges caution when considering the use of Meridia," says Robert H. Eckel, M.D., vice chairperson of the American Heart Association's Nutrition Committee and professor of medicine at the University of Colorado Health Sciences Center. "Although early trials of the drug showed it to be modestly effective, the drug raised concerns because in some individuals it elevates blood pressure." High blood pressure is a serious risk factor for heart attack and stroke. In addition, some individuals experienced increased pulse rates and/or irregular heartbeats.

Prior to drug approval, evidence was provided that the drug was not associated with valvular heart disease, as was the case with fenfluramine and Redux, says Eckel.

"Before definitive data are available, patients and their physicians should carefully weigh the benefits vs. the risks of using this new medication. It is especially important that this drug be considered only for people for whom obesity poses a health risk," he says.

Like Redux and fenfluramine, Meridia in part reduces a person's appetite by interacting with serotonin, a chemical in the brain that makes people feel full.

Obesity, an increasingly prevalent problem in the United States, is also emerging as an independent as well as a contributing risk factor for diseases of the heart, according to a recent science advisory from the American Heart Association. The statement, "Obesity and Heart Disease," was published in the association's journal Circulation (Nov. 4, 1997).

According to the statement, small increases in a person's body mass index (BMI) are associated with an increased risk of both nonfatal and fatal heart attacks, even if the individual has no other risk factors for heart attack. In addition, overweight individuals (BMI above 25) are at greater risk for developing other major risk factors for heart attacks, such as high blood pressure, high cholesterol and diabetes mellitus. Body mass index is defined as weight in kilograms divided by height in meters squared and is considered a better measure of obesity than weight because it more closely approximates the amount of fat on an individual's body.

For people with BMI between 25 and 30, eating a lower-calorie, low-fat diet and becoming more physically active are very helpful at improving overall health. For people with a BMI over 30, treatment with weight loss drugs may be appropriate.

The American Heart Association emphasizes that individuals should use caution and be under a physician's care when taking weight-loss drugs.

American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to